Literature DB >> 8529884

Multiple cloning sites carrying loxP and FRT recognition sites for the Cre and Flp site-specific recombinases.

M R Snaith1, J A Murray, C A Boulter.   

Abstract

Plasmids were constructed carrying the loxP and FRT recognition sites for the Cre and Flp site-specific recombinases, respectively, within multiple cloning sites. Vectors carrying single and tandemly repeated targets are available with various flanking restriction enzyme sites. In addition, a series of plasmids carrying both loxP and FRT sites is available. These vectors facilitate construction of target molecules for these site-specific recombinases which are becoming increasingly important tools for the in vivo manipulation of DNA.

Mesh:

Substances:

Year:  1995        PMID: 8529884     DOI: 10.1016/0378-1119(95)00579-8

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

1.  Cell growth inhibition upon deletion of four toxin-antitoxin loci from the megaplasmids of Sinorhizobium meliloti.

Authors:  Branislava Milunovic; George C diCenzo; Richard A Morton; Turlough M Finan
Journal:  J Bacteriol       Date:  2013-12-06       Impact factor: 3.490

2.  Stable recombinase-mediated cassette exchange in Arabidopsis using Agrobacterium tumefaciens.

Authors:  Jeanine D Louwerse; Miranda C M van Lier; Dirk M van der Steen; Clementine M T de Vlaam; Paul J J Hooykaas; Annette C Vergunst
Journal:  Plant Physiol       Date:  2007-10-05       Impact factor: 8.340

3.  High efficiency, site-specific excision of a marker gene by the phage P1 cre-loxP system in the yellow fever mosquito, Aedes aegypti.

Authors:  Nijole Jasinskiene; Craig J Coates; Aurora Ashikyan; Anthony A James
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

4.  Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.

Authors:  David A Garber; Leigh A O'Mara; Jun Zhao; Sailaja Gangadhara; InChul An; Mark B Feinberg
Journal:  PLoS One       Date:  2009-05-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.